Document is current
Any future updates will be listed below
-
Authors
Moreno-Mateos, Miguel A.
Fernandez, Juan P.
Rouet, Romain
Vejnar, Charles E.
Lane, Maura A.
Mis, Emily
Khokha, Mustafa K.
Doudna, Jennifer A. https://orcid.org/0000-0001-9161-999X
Giraldez, Antonio J.
- License Information
-
More Information
Article History
Received: 12 May 2017
Accepted: 18 October 2017
First Online: 8 December 2017
Competing interests
: J.A.D. is employed by the Howard Hughes Medical Institute (HHMI) and works at the University at California (UC), Berkeley, USA. UC Berkeley and HHMI have patents pending for CRISPR technologies on which J.A.D. is an inventor. J.A.D. is the executive director of the Innovative Genomics Institute (IGI) at UC Berkeley and University of California, San Francisco. J.A.D. is a co-founder of Editas Medicine, Intellia Therapeutics and Caribou Biosciences, and a scientific adviser to Caribou, Intellia, eFFECTOR Therapeutics and Driver. The remaining authors declare no competing financial interests.
